Kai Wang

机构：Chinese Academy of Sciences, Shanghai Institute of Materia Medica · ORCID：0000-0002-7597-549X

发表论文 7 篇 · 总被引 45 次 · h-index 5

代表论文

• Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists (2023 · Journal of Medicinal Chemistry · 被引 18)
• Discovery of pyridazinone derivatives bearing tetrahydroimidazo[1,2-a]pyrazine scaffold as potent inhibitors of transient receptor potential canonical 5 to ameliorate hypertension-induced renal injury in rats (2024 · European Journal of Medicinal Chemistry · 被引 8)
• A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency (2024 · Bioorganic & Medicinal Chemistry · 被引 7)
• Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD (2023 · Bioorganic & Medicinal Chemistry · 被引 6)
• Property-Based Design of Xanthine Derivatives as Potent and Orally Available TRPC4/5 Inhibitors for Depression and Anxiety (2025 · Journal of Medicinal Chemistry · 被引 5)
• Quantitative Mass Spectrometry Imaging of Amino Acids Enabled by Pyridinium Salt MALDI Probe (2025 · Analytical Chemistry · 被引 2)